Asparagus adscendens (Shweta musali) stimulates insulin secretion, insulin action and inhibits starch digestion

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Diabetes mellitus is a complex metabolic disease characterised by glucose overproduction and under-utilisation. As the incidence of diabetes expands rapidly across the globe there is an urgent need to expand the range of effective treatments. Higher plants such as Asparagus adscendens provide therapeutic opportunities and a rich source of potential antidiabetic agents. In the present study an aqueous extract of Asparagus adscendens was shown to induce a significant non-toxic 19-248 % increase in glucose-dependent insulinotropic actions (P <0.001) in the clonal pancreatic beta cell line, BRIN-BD11. In addition, the extract produced an 81 % (P <0.0001) increase in glucose uptake in 3T3-L1 adipocytes. Asparagus adscendens also produced a 21 % (P <0.001) decrease in starch digestion in vitro. The present study has revealed the presence of insulinotropic, insulin-enhancing activity and inhibitory effects on starch digestion in Asparagus adscendens. The former actions are dependent on the active principle(s) in the plant being absorbed intact. Future work assessing its use as a dietary adjunct or as a source of active components may provide new opportunities for the treatment of diabetes.
LanguageEnglish
Pages576-581
JournalBRITISH JOURNAL OF NUTRITION
Volume95
Issue number3
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Starch
Digestion
Insulin
Glucose
Metabolic Diseases
Insulin-Secreting Cells
Hypoglycemic Agents
Adipocytes
Diabetes Mellitus
Cell Line
Incidence
Therapeutics
In Vitro Techniques

Cite this

@article{714657e9523f4939b5a58f4758831d61,
title = "Asparagus adscendens (Shweta musali) stimulates insulin secretion, insulin action and inhibits starch digestion",
abstract = "Diabetes mellitus is a complex metabolic disease characterised by glucose overproduction and under-utilisation. As the incidence of diabetes expands rapidly across the globe there is an urgent need to expand the range of effective treatments. Higher plants such as Asparagus adscendens provide therapeutic opportunities and a rich source of potential antidiabetic agents. In the present study an aqueous extract of Asparagus adscendens was shown to induce a significant non-toxic 19-248 {\%} increase in glucose-dependent insulinotropic actions (P <0.001) in the clonal pancreatic beta cell line, BRIN-BD11. In addition, the extract produced an 81 {\%} (P <0.0001) increase in glucose uptake in 3T3-L1 adipocytes. Asparagus adscendens also produced a 21 {\%} (P <0.001) decrease in starch digestion in vitro. The present study has revealed the presence of insulinotropic, insulin-enhancing activity and inhibitory effects on starch digestion in Asparagus adscendens. The former actions are dependent on the active principle(s) in the plant being absorbed intact. Future work assessing its use as a dietary adjunct or as a source of active components may provide new opportunities for the treatment of diabetes.",
author = "JN Mathews and Peter Flatt and Yasser Abdel-Wahab",
year = "2006",
month = "3",
doi = "10.1079/BJN20051650",
language = "English",
volume = "95",
pages = "576--581",
journal = "British Journal of Nutrition",
issn = "0007-1145",
publisher = "Cambridge University Press",
number = "3",

}

TY - JOUR

T1 - Asparagus adscendens (Shweta musali) stimulates insulin secretion, insulin action and inhibits starch digestion

AU - Mathews, JN

AU - Flatt, Peter

AU - Abdel-Wahab, Yasser

PY - 2006/3

Y1 - 2006/3

N2 - Diabetes mellitus is a complex metabolic disease characterised by glucose overproduction and under-utilisation. As the incidence of diabetes expands rapidly across the globe there is an urgent need to expand the range of effective treatments. Higher plants such as Asparagus adscendens provide therapeutic opportunities and a rich source of potential antidiabetic agents. In the present study an aqueous extract of Asparagus adscendens was shown to induce a significant non-toxic 19-248 % increase in glucose-dependent insulinotropic actions (P <0.001) in the clonal pancreatic beta cell line, BRIN-BD11. In addition, the extract produced an 81 % (P <0.0001) increase in glucose uptake in 3T3-L1 adipocytes. Asparagus adscendens also produced a 21 % (P <0.001) decrease in starch digestion in vitro. The present study has revealed the presence of insulinotropic, insulin-enhancing activity and inhibitory effects on starch digestion in Asparagus adscendens. The former actions are dependent on the active principle(s) in the plant being absorbed intact. Future work assessing its use as a dietary adjunct or as a source of active components may provide new opportunities for the treatment of diabetes.

AB - Diabetes mellitus is a complex metabolic disease characterised by glucose overproduction and under-utilisation. As the incidence of diabetes expands rapidly across the globe there is an urgent need to expand the range of effective treatments. Higher plants such as Asparagus adscendens provide therapeutic opportunities and a rich source of potential antidiabetic agents. In the present study an aqueous extract of Asparagus adscendens was shown to induce a significant non-toxic 19-248 % increase in glucose-dependent insulinotropic actions (P <0.001) in the clonal pancreatic beta cell line, BRIN-BD11. In addition, the extract produced an 81 % (P <0.0001) increase in glucose uptake in 3T3-L1 adipocytes. Asparagus adscendens also produced a 21 % (P <0.001) decrease in starch digestion in vitro. The present study has revealed the presence of insulinotropic, insulin-enhancing activity and inhibitory effects on starch digestion in Asparagus adscendens. The former actions are dependent on the active principle(s) in the plant being absorbed intact. Future work assessing its use as a dietary adjunct or as a source of active components may provide new opportunities for the treatment of diabetes.

U2 - 10.1079/BJN20051650

DO - 10.1079/BJN20051650

M3 - Article

VL - 95

SP - 576

EP - 581

JO - British Journal of Nutrition

T2 - British Journal of Nutrition

JF - British Journal of Nutrition

SN - 0007-1145

IS - 3

ER -